Skip to content

Clinical trials

Phase 1/2 Sudden Infant Death trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sudden Infant Death Phase: Phase 1/2 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20111
20171
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Denali Therapeutics Inc.1
Green Cross Corporation1
REGENXBIO Inc.1
Sangamo Therapeutics1
Shire1
Takeda1
Talaris Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II7
Sudden Infant Death7
Lysosomal Storage Diseases2
Adrenoleukodystrophy1
Leukodystrophy, Globoid Cell1
Leukodystrophy, Metachromatic1
Mucopolysaccharidoses1
Mucopolysaccharidosis I1
Mucopolysaccharidosis III1
Niemann-Pick Diseases1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.